TNF INHIBITORS ARE PRODUCED SPONTANEOUSLY BY RHEUMATOID AND OSTEOARTHRITIC SYNOVIAL JOINT CELL-CULTURES - EVIDENCE OF FEEDBACK-CONTROL OF TNF ACTION

被引:48
作者
BRENNAN, FM
GIBBONS, DL
COPE, AP
KATSIKIS, P
MAINI, RN
FELDMANN, M
机构
[1] Kennedy Institute of Rheumatology, London, W6 8LW, Sunley Building, Lurgan Avenue
基金
英国惠康基金;
关键词
D O I
10.1111/j.1365-3083.1995.tb03639.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have proposed the hypothesis that tumour necrosis factor alpha (TNF-alpha) has a pivotal role in the pathogenesis of rheumatoid arthritis, based on in vitro observations that in RA synovial joint cell cultures removal of TNF-alpha, inhibited other potentially pathogenic cytokines such as the equally proinflammatory cytokine interleukin 1 (IL-1) and the macrophage activating factor, GM-CSF. Here we describe that in both rheumatoid (RA) and osteoarthritic (OA) synovial cultures there is a homeostatic mechanism to regulate the activities of TNF-alpha. This concept is based on several observations. First in these synovial joint cell cultures the substantial discrepancy between the levels of bioactive and immunoreactive TNF-alpha indicates the presence of an inhibitor. Second, TNF binding proteins are produced spontaneously, which are the soluble variants of surface p75 and p55 TNF receptor. The amount of soluble TNF receptors (sTNF-R) produced varied between cultures; p75 sTNF-R was more abundant than p55 sTNF-R (as detected by ELISA), and both were produced at higher levels by RA synovial joint cells in culture, compared to OA cultures. These TNF binding proteins act as endogenous inhibitors of TNF-alpha, since blocking their activity in synovial joint cell culture supernatants with MoAb to p55 and p75 sTNF-R enhanced their cytotoxic activity in the TNF bioassay. The regulation of production of these sTNF-R in synovial joint cell cultures is important as the balance between TNF-ct and sTNF-R production may determine the outcome of the inflammatory process.
引用
收藏
页码:158 / 165
页数:8
相关论文
共 38 条
[1]  
ADERKA D, 1991, CANCER RES, V51, P5602
[2]   INTERLEUKIN-1 RECEPTOR ANTAGONIST - A NEW MEMBER OF THE INTERLEUKIN-1 FAMILY [J].
AREND, WP .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1445-1451
[3]   ENHANCED EXPRESSION OF TUMOR-NECROSIS-FACTOR RECEPTOR MESSENGER-RNA AND PROTEIN IN MONONUCLEAR-CELLS ISOLATED FROM RHEUMATOID-ARTHRITIS SYNOVIAL JOINTS [J].
BRENNAN, FM ;
GIBBONS, DL ;
MITCHELL, T ;
COPE, AP ;
MAINI, RN ;
FELDMANN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (07) :1907-1912
[4]  
BRENNAN FM, 1992, BRIT J RHEUMATOL, V31, P293
[5]  
BRENNAN FM, 1989, LANCET, V2, P244
[6]   LOCALIZATION OF TUMOR-NECROSIS-FACTOR-ALPHA IN SYNOVIAL TISSUES AND AT THE CARTILAGE PANNUS JUNCTION IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
CHU, CQ ;
FIELD, M ;
FELDMANN, M ;
MAINI, RN .
ARTHRITIS AND RHEUMATISM, 1991, 34 (09) :1125-1132
[7]   INCREASED LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN THE SERA AND SYNOVIAL-FLUID OF PATIENTS WITH RHEUMATIC DISEASES [J].
COPE, AP ;
ADERKA, D ;
DOHERTY, M ;
ENGELMANN, H ;
GIBBONS, D ;
JONES, AC ;
BRENNAN, FM ;
MAINI, RN ;
WALLACH, D ;
FELDMANN, M .
ARTHRITIS AND RHEUMATISM, 1992, 35 (10) :1160-1169
[8]   LOCALIZATION OF TUMOR-NECROSIS-FACTOR RECEPTORS IN THE SYNOVIAL TISSUE AND CARTILAGE PANNUS JUNCTION IN PATIENTS WITH RHEUMATOID-ARTHRITIS - IMPLICATIONS FOR LOCAL ACTIONS OF TUMOR-NECROSIS-FACTOR-ALPHA [J].
DELEURAN, BW ;
CHU, CQ ;
FIELD, M ;
BRENNAN, FM ;
MITCHELL, T ;
FELDMANN, M ;
MAINI, RN .
ARTHRITIS AND RHEUMATISM, 1992, 35 (10) :1170-1178
[9]   RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS [J].
ELLIOTT, MJ ;
MAINI, RN ;
FELDMANN, M ;
KALDEN, JR ;
ANTONI, C ;
SMOLEN, JS ;
LEEB, B ;
BREEDVELD, FC ;
MACFARLANE, JD ;
BIJL, H ;
WOODY, JN .
LANCET, 1994, 344 (8930) :1105-1110
[10]  
ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362